
Portable FDA-cleared eye screening camera with AI disease detection software.
By Tanmay Verma, Founder · Last verified 03 Jul 2026
In short
AI Optics — Portable FDA-cleared eye screening camera with AI disease detection software. Best for Primary care clinics integrating eye disease screening into routine checkups, Retail health chains offering preventive vision services, Long-term care facilities monitoring residents for diabetic retinopathy. Contact Sales pricing.
See what real users actually say. We scan live discussions, reviews and complaints across the web and hand you an honest verdict — in under a minute.
3 free scans · no card needed · downloadable report
A promising handheld eye screening system with FDA-cleared hardware, but the AI diagnostic software remains investigational. Worth evaluating for pilot studies and FDA approval track—but full deployment is not yet possible.
Compare with: AI Optics vs Paige AI, AI Optics vs Nanox.AI, AI Optics vs Mindsera
Last verified: July 2026
We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.
16 mentions across 2 sources (Hacker News, Lemmy).
How likely is AI Optics to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.
Last calculated: July 2026
How we score →AI Optics is transforming point-of-care diagnostics with a handheld, FDA-cleared imaging camera and AI-based screening software. The Sentinel Camera captures high-quality digital images of the human eye using proprietary optical technology, while the Sentinel Pro module (investigational) analyzes images to detect Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma. Designed for primary care, optometry, retail health, and long-term care settings, the system aims to reduce barriers to specialist access by enabling instant, cost-effective screening at the point of care. Key features include a portable handheld form factor, FDA clearance for the hardware, and an easy-to-use interface for non-specialists. The Sentinel Pro software delivers on-device AI analysis, providing immediate results without requiring cloud connectivity. HIPAA-compliant data handling ensures patient privacy. AI Optics targets a critical gap in preventive eye care, where many patients delay or skip specialist visits due to cost or access issues. Compared to traditional tabletop fundus cameras, AI Optics offers a lower-cost, more portable solution. However, the AI screening module is still pending regulatory clearance, limiting its current use to investigational settings. Systems like EyeArt or IDx-DR have fully cleared AI, but AI Optics' integrated hardware-software approach and focus on multiple diseases give it a unique position. For pilot programs in retail health or primary care, it’s a strong contender once the software gains approval.
AI Optics addresses a real bottleneck in eye care: access to specialists. Many patients with diabetes or age-related risks never get screened due to cost, distance, or inconvenience. The Sentinel Camera is already FDA-cleared, which is a solid foundation. The proprietary optics deliver good image quality in a portable package. However, the core value—AI-driven diagnosis—isn't commercially available yet. Sentinel Pro is 'for investigational use only,' per the vendor. That limits current buyers to research and pilot programs. If you need a cleared AI screening tool today, look at IDx-DR or EyeArt. If you want to future-proof with a hardware platform, AI Optics might be the pick. In practice, the handheld format is a differentiator. Most competitors use tabletop units or smartphone adapters. The Sentinel Camera is purpose-built, which may improve image consistency. But without pricing transparency (contact sales only), adoption could be slow. We'd reach for this when running a clinical study or building a new screening protocol. For immediate deployment in a clinic, pass for now—wait for FDA clearance on the software. The company is based in NYC and seems focused on the US market, so international buyers should check regulatory status.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Common stack mates teams adopt alongside AI Optics, with the specific reason each pairing earns its keep.
Used AI Optics? Help shape our editorial sentiment research.